Daily Edition · Page 1

THE DAILY INDEX

Technology, AI, software, security, crypto and business

Across today’s newsletters

Today’s Index

DOXXING NEARLY ANYONE IN AMERICA FOR $15

An investigation from 404 Media details a category of bots that utilizes credit headers to dox nearly anyone in America. Hackers seem to have acquired access to this data and are selling it for $15-$40. 404 Media has confirmed that at least some of the extensive data is accurate. Data that the tool provides include addresses, mobile phone numbers, email addresses, driver's license numbers, and even names and birth years of the target’s relatives.

MAKERDAO CO-FOUNDER FLOATS USING SOLANA’S CODE TO BUILD NEW CHAIN

MakerDAO's co-founder, Rune Christensen, recently proposed using the Solana codebase for a dedicated appchain aiming to improve the DeFi lending protocol. This new appchain, part of MakerDAO's five-phases Endgame strategy, aims to improve governance and sustainability. Maker will not be directly building on Solana, but rather will be using the Solana stack. This proposal could potentially lead to a mutually beneficial relationship between MakerDAO and Solana.

ARE SELF-DRIVING CARS ALREADY SAFER THAN HUMAN DRIVERS?

Waymo and Cruise have driven a combined total of over 8 million driverless miles. The two companies have reported 102 crashes, with most of the crashes being low-speed collisions that did not pose a serious safety risk and a large majority being the fault of the other driver. It will still take hundreds of millions more driverless miles to answer the question of whether driverless cars are safer than human drivers, but the evidence is starting to pile up.

CAN AN ARTIFICIAL KIDNEY FINALLY FREE PATIENTS FROM DIALYSIS?

Kidney cells housed within the Kidney Project's bioreactor can survive inside the body of a pig and mimic several important kidney functions for at least one week. The Kidney Project aims to create a device that can improve on dialysis. A bioartificial kidney would make treatments for kidney disease more effective, tolerable, and comfortable. The next steps for testing will be month-long trials, first in animals and then eventually in humans.

TLDR IndexPage 1